Pries
Axel Pries, Berlin DE
Patent application number | Description | Published |
---|---|---|
20120059245 | METHOD AND DEVICE FOR MONITORING AND IMPROVING ARTERIOGENESIS - A method for determining an arteriovascular condition of a subject having an arterial blood flow is shown. The method involves determining a temporal progression of an instantaneous blood flow condition of the arterial blood flow as well as deriving a slew rate of the temporal progression during an increase of the temporal progression. In addition, an arteriovascular condition indicator device is shown, which comprises: an input for receiving an input signal representing an instantaneous arterial blood flow condition of a subject and a slew rate monitor connected to the input. A corresponding control device for providing an activation signal is also shown. The control device comprises a maximum detector connected to the slew rate monitor. A method for stimulation of arteriogenesis is also shown, wherein a temporal progression of an instantaneous blood flow condition is monitored, a slew rate of the temporal progression is derived, and the maximum of the slew rate is determined. An external pressure is applied repeatedly to the arteriovascular section in synchronization with the occurrence of the determined maximum. | 03-08-2012 |
Malte Pries, Gottingen DE
Patent application number | Description | Published |
---|---|---|
20140127523 | Functionalized Polyorganosiloxanes Or Silanes For The Treatment Of Lignocellulosic Materials - The present invention relates to functionalized polyorganosiloxanes or silanes for the treatment of lignocellulosic materials. | 05-08-2014 |
Robert A. Pries, Broomfield, CO US
Patent application number | Description | Published |
---|---|---|
20090262471 | Arc Fault Circuit Interrupter (AFCI) Support - An Arc Fault Circuit Interrupter support system and program, having a plurality of sequenced individual loads arranged in scenes or groups, which sequenced individual loads when activated together form a cumulative total of 800 watts or more; and one or both of a delay between each sequenced individual load to prevent the cumulative wattage from creating a nuisance Arc Fault Circuit Interrupter breaker trip, and a plurality of pre-heat pulses provided to individual loads with individual wattages of 800 watts or more prior to applying a full current to the individual load. | 10-22-2009 |
Tanja Pries US
Patent application number | Description | Published |
---|---|---|
20150328277 | ORAL TRANSMUCOSAL DELIVERY OF GLATIRAMER ACETATE - The present invention provides an oral patch comprising: | 11-19-2015 |
Tanja Pries, Munich DE
Patent application number | Description | Published |
---|---|---|
20150328277 | ORAL TRANSMUCOSAL DELIVERY OF GLATIRAMER ACETATE - The present invention provides an oral patch comprising: | 11-19-2015 |
Verena Pries, Essen DE
Patent application number | Description | Published |
---|---|---|
20120316192 | SUBSTITUTED INDOLO [2,3-A] QUINOLIZINES - The present invention relates to novel substituted indolo[2,3-a]quinolizines and stereoisomeric forms thereof and/or pharmaceutically acceptable salts of these compounds as well as pharmaceutical compositions containing at least one of these substituted indolo[2,3-a]quinolizines together with pharmaceutically acceptable carrier, excipient and/or diluents. Said novel substituted indolo[2,3-a]quinolizines have been identified as useful for the prophylaxis and treatment of cancer by the induction of strong mitotic delays, chromosomal misalignments and mitotic tri- and multipolarization leading to cell cycle stop and apoptosis. Furthermore a synthesis for preparation of the substituted indolo[2,3-a]quinolizines is disclosed in the present invention. | 12-13-2012 |